Claudia Beato

Verona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Structural basis for high-affinity inhibitor binding to lipid kinases PIP4K2A and PIP4K2B.

Structural basis for high-affinity inhibitor binding to lipid kinases PIP4K2A and PIP4K2B.

Journal: Acta crystallographica. Section D, Structural biology

Published: February 17, 2026

Drug design strategies for the selective targeting of lung, liver and kidney.

Drug design strategies for the selective targeting of lung, liver and kidney.

Journal: Progress in medicinal chemistry

Published: October 23, 2025

PIP4K2A/2B inhibitor suppresses tumor growth in a xenograft model of NSCLC.

PIP4K2A/2B inhibitor suppresses tumor growth in a xenograft model of NSCLC.

Journal: iScience

Published: June 03, 2025

Development of retinoid nuclear receptor pathway antagonists through targeting aldehyde dehydrogenase 1A3.

Development of retinoid nuclear receptor pathway antagonists through targeting aldehyde dehydrogenase 1A3.

Journal: iScience

Published: February 12, 2025

Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis.

Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis.

Journal: ACS medicinal chemistry letters

Published: November 21, 2024

Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.

Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.

Journal: Journal of medicinal chemistry

Published: April 05, 2023

Brain-penetrant cyanoindane and cyanotetralin inhibitors of G2019S-LRRK2 kinase activity.

Brain-penetrant cyanoindane and cyanotetralin inhibitors of G2019S-LRRK2 kinase activity.

Journal: Bioorganic & medicinal chemistry letters

Published: November 05, 2022

Fine tuning for success in structure-based virtual screening.

Fine tuning for success in structure-based virtual screening.

Journal: Journal of computer-aided molecular design

Published: July 09, 2021

Selective Inhibitors of G2019S-LRRK2 Kinase Activity.

Selective Inhibitors of G2019S-LRRK2 Kinase Activity.

Journal: Journal of medicinal chemistry

Published: November 16, 2020

Aspergillus fumigatus tryptophan metabolic route differently affects host immunity.

Aspergillus fumigatus tryptophan metabolic route differently affects host immunity.

Journal: Cell reports

Published: August 12, 2019

Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents.

Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents.

Journal: Journal of medicinal chemistry

Published: January 28, 2017

Rational Design, Synthesis, and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella typhimurium O-Acetylserine Sulfhydrylase.

Rational Design, Synthesis, and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella typhimurium O-Acetylserine Sulfhydrylase.

Journal: Journal of medicinal chemistry

Published: February 20, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026